Plant ID: NPO13332
Plant Latin Name: Tacca chantrieri
Taxonomy Genus: Tacca
Taxonomy Family: Taccaceae
NCBI TaxonomyDB:
85283
Plant-of-the-World-Online:
827891-1
Bangladesh; Myanmar; India; Cambodia; Vietnam; China; Laos; Thailand
NPSR1; TSHR; | |
TDP1; PTGES; BRCA1; | |
MAOA; | |
TLR9; | |
HIF1A; | |
APP; HTT; MAPT; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | PTGES | Prostaglandin E synthase | O14684 | CHEMBL5658 |
Enzyme_unclassified | BRCA1 | Breast cancer type 1 susceptibility protein | P38398 | CHEMBL5990 |
Oxidoreductase | MAOA | Monoamine oxidase A | P21397 | CHEMBL1951 |
Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Toll-like and Il-1 receptors | TLR9 | Toll-like receptor 9 | Q9NR96 | CHEMBL5804 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | APP | Beta amyloid A4 protein | P05067 | CHEMBL2487 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0032501; multicellular organismal process | GO:0032640; tumor necrosis factor production | 1.768E-06 | 6.983E-03 | APP, TLR9 |
BP | GO:0009987; cellular process | GO:0008088; axo-dendritic transport | 1.924E-06 | 6.983E-03 | APP, HIF1A, MAPT |
BP | GO:0051179; localization | GO:0060341; regulation of cellular localization | 3.447E-06 | 1.072E-02 | APP, HIF1A, HTT, MAPT, NPSR1, TLR9 |
BP | GO:0009987; cellular process | GO:1990000; amyloid fibril formation | 8.240E-06 | 1.468E-02 | APP, MAPT |
CC | GO:0044464; cell part | GO:0005641; nuclear envelope lumen | 8.240E-06 | 1.468E-02 | APP, PTGES |
BP | GO:0032501; multicellular organismal process | GO:0048143; astrocyte activation | 1.059E-05 | 1.537E-02 | APP, MAPT |
MF | GO:0005488; binding | GO:0034452; dynactin binding | 1.617E-05 | 1.806E-02 | HTT, MAPT |
MF | GO:0005488; binding | GO:0031072; heat shock protein binding | 2.495E-05 | 2.587E-02 | HIF1A, HTT, MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.654E-03 | 6.781E-02 | APP, MAOA |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 3.670E-03 | 7.492E-02 | APP, MAPT |
09100 Metabolism | 09105 Amino acid metabolism | hsa00360 | Phenylalanine metabolism | 9.313E-03 | 7.492E-02 | MAOA |
09100 Metabolism | 09105 Amino acid metabolism | hsa00350 | Tyrosine metabolism | 1.909E-02 | 7.492E-02 | MAOA |
09160 Human Diseases | 09167 Infectious diseases | hsa05143 | African trypanosomiasis | 1.909E-02 | 7.492E-02 | TLR9 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 2.179E-02 | 7.492E-02 | MAOA |
09160 Human Diseases | 09161 Cancers | hsa05211 | Renal cell carcinoma | 3.572E-02 | 7.492E-02 | HIF1A |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 3.625E-02 | 7.492E-02 | HIF1A |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 3.731E-02 | 7.492E-02 | MAOA |
09150 Organismal Systems | 09152 Endocrine system | hsa04918 | Thyroid hormone synthesis | 3.837E-02 | 7.492E-02 | TSHR |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
L00-L99: Diseases of the skin and subcutaneous tissue | Vitiligo | L80 | MAOA; |
I00-I99: Diseases of the circulatory system | Neurological disease | I21, I22, R52, R52.1-R52.2, R60.9, G89 | NPSR1; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | MAOA; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Major depressive disorder | F32, F33, M32 | MAOA; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | MAOA; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | MAOA; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Alcohol use disorders | F10.2 | MAOA; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Mood disorder | F30-F39 | MAOA; |
G00-G99: Diseases of the nervous system G00-G99 | Epilepsy | G40 | MAOA; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAOA; PTGES; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Depression | F30-F39 | MAOA; |